BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17879862)

  • 21. Characteristics of symptomatic reflux episodes on Acid suppressive therapy.
    Tutuian R; Vela MF; Hill EG; Mainie I; Agrawal A; Castell DO
    Am J Gastroenterol; 2008 May; 103(5):1090-6. PubMed ID: 18445095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
    Pohl D; Tutuian R
    Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined pH-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms.
    Bajbouj M; Becker V; Neuber M; Schmid RM; Meining A
    Digestion; 2007; 76(3-4):223-8. PubMed ID: 18174685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
    Pritchett JM; Aslam M; Slaughter JC; Ness RM; Garrett CG; Vaezi MF
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):743-8. PubMed ID: 19281866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weakly acidic reflux.
    Tack J; Blondeau K
    Dig Dis; 2009; 27(1):58-61. PubMed ID: 19439962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Esophageal motility in nonacid reflux compared with acid reflux.
    Wang VS; Feldman N; Maurer R; Burakoff R
    Dig Dis Sci; 2009 Sep; 54(9):1926-32. PubMed ID: 19051027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intraluminal impedance technique in the diagnosis of apparent life-threatening events (ALTE)].
    Cendón RG; Jiménez MJ; Valdés JA; Fernández Pineda I; Limousin IT; López-Alonso M
    Cir Pediatr; 2008 Jan; 21(1):11-4. PubMed ID: 18444383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring.
    Sharma N; Agrawal A; Freeman J; Vela MF; Castell D
    Clin Gastroenterol Hepatol; 2008 May; 6(5):521-4. PubMed ID: 18356117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gastroesophageal reflux disease--diagnosis and management].
    Wojtuń S; Gil J; Jałocha Ł; Błaszak A; Wojtkowiak M
    Pol Merkur Lekarski; 2009 May; 26(155):512-6. PubMed ID: 19606713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [GERD related respiratory symptoms: diagnosis and treatment].
    Cuenca-Abente F; Faerberg A; Marty PF; Corti R
    Acta Gastroenterol Latinoam; 2006 Mar; 36(1):42-50. PubMed ID: 16706077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of body positioning on gastroesophageal reflux in premature infants: evaluation by combined impedance and pH monitoring.
    Corvaglia L; Rotatori R; Ferlini M; Aceti A; Ancora G; Faldella G
    J Pediatr; 2007 Dec; 151(6):591-6, 596.e1. PubMed ID: 18035136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acid and nonacid reflux monitoring.
    Carlson DA; Pandolfino JE
    Gastroenterol Clin North Am; 2014 Mar; 43(1):89-104. PubMed ID: 24503361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nocturnal gastroesophageal reflux as a cause of refractory chronic laryngitis--pathophysiology and management].
    Konermann M; Radü B; Liebetrau M; Rawert B; Heimbucher J; Sanner BM
    Wien Med Wochenschr; 1999; 151(5-6):142-6. PubMed ID: 11315414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New technologies to evaluate esophageal function.
    Ravi K; Francis DL
    Expert Rev Med Devices; 2007 Nov; 4(6):829-37. PubMed ID: 18035949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impedance-pH monitoring: new standard for measuring gastro-oesophageal reflux.
    Bredenoord AJ
    Neurogastroenterol Motil; 2008 May; 20(5):434-9. PubMed ID: 18416700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Multiple Intraluminal Impedance measurement in the esophagus. Experience with the first 100 Danish patients].
    Dalby K; Markøw S; Pontø CH; Kruse-Andersen S
    Ugeskr Laeger; 2007 Oct; 169(42):3579-83. PubMed ID: 18031670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ten-year outcome of laparoscopic and conventional nissen fundoplication: randomized clinical trial.
    Broeders JA; Rijnhart-de Jong HG; Draaisma WA; Bredenoord AJ; Smout AJ; Gooszen HG
    Ann Surg; 2009 Nov; 250(5):698-706. PubMed ID: 19801931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic difficulties during combined multichannel intraluminal impedance and pH monitoring in patients with esophagitis or Barrett's esophagus.
    Waśko-Czopnik D; Błoński W; Paradowski L
    Adv Med Sci; 2007; 52():196-8. PubMed ID: 18217418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precise role of acid in non-erosive reflux disease.
    Wang C; Hunt RH
    Digestion; 2008; 78 Suppl 1():31-41. PubMed ID: 18832838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.